Supplemental Issues of The Diabetes Educator

• Volume 34, Supplement 2, March/April 2008: Strategies for Cardiometabolic Risk Factor Reduction: The Emerging Role of the Endocannabinoid System,
• Volume 34, Supplement 1, January/February 2008: A Clinical Imperative: Strategies to Effectively Improve Treatment Outcomes With Amylin Analogues

• Volume 33, Supplement 7, July/August 2007: The Tipping Point: Overcoming Psychological Insulin Resistance

• Volume 33, Supplement 6, June 2007: Promising Approaches to Diabetes Self-Management: Lessons From the Diabetes Initiative of the Robert Wood Johnson Foundation

• Volume 33, Supplement 5, May/June 2007: Multidisciplinary Approach in Addressing Novel Mechanisms in the Management of Type 2 Diabetes

• Volume 33, Supplement 4, April 2007: The Other “Insulin Resistance”: Overcoming Barriers to Insulin Use and Encouraging Diabetes Self-management

• Volume 33, Supplement 3, March/April 2007: The Why and How of Early Intervention With Insulin Analogs

• Volume 33, Supplement 2, February 2007: Through the Looking Glass: Current and Future Perspectives on the Role of Hormonal Interplay in Glucose Homeostasis

• Volume 33, Supplement 1, January/February 2007: Clinical Case Challenge: Measuring the Benefits of Integrating Incretin Mimetics Into Management of Type 2 Diabetes

• Volume 32, Supplement 5, July/August 2006: Cardiovascular Event Prevention in the Person With Type 2 Diabetes: Case Examples for Identifying and Treating Multiple Risks

• Volume 32, Supplement 4, June 2006: Early Intervention for Optimal Outcomes

• Volume 32, Supplement 3, May/June 2006: Insulin and Amylin: Restoring Balance in Glycemic Control

• Volume 32, Supplement 2, March/April 2006: Incretin-Based Therapies: Achieving Better Glycemic Control in Type 2 Diabetes

• Volume 32, Supplement 1, January/February 2006: Overcoming Barriers and Challenges to Glycemic Control-Insulin and Insulin Pump Therapy: Opportunities for Diabetes Educators to Systematically Improve Glycemic Control